Top cancer drugs may come under price control

Taking cue from the WHO’s revised list of essential medicines, popular biosimilars for cancer cure may get incorporated in India’s revised National List of Essential Medicines.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2QO57Uq
via IFTTT